Moreover, mounting experimental and clinical evidence have also suggested a central role for the signaling networks operating to promote a metastatic and/or therapeutic resistance cascade in cancer development that involves interactions of AR, TMPRSS2, HGF and c-MET with critical components of TMEs [61]. This evidence concerns the gene MET and cancer.